Canadian Flag Transport Canada / Transports Canada Government of Canada
Common menu bar (access key: M)
Skip to specific page links (access key: 1)
Transport Canada Civil Aviation
Foreword
Section 1
Section 2
Neurology
Cardiovascular
Diabetes
Asthma
Other Policies
Contacts
Alternate Formats
Skip all menus (access key: 2)
Transport Canada > Civil Aviation > Civil Aviation Medicine > TP 13312 - Handbook for Civil Aviation Medical Examiners > TP 13312 - Handbook for Civil Aviation Medical Examiners

Introduction

The practice of aeromedical certification of pilots and air traffic controllers with diabetes in most Contracting States of the International Civil Aviation Organization, including Canada, has been fairly consistent and has not changed for many years. Applicants with diabetes whose condition can be controlled by dietary measures alone are permitted to fly and control air traffic. All others requiring medication for this common disorder are assessed as “unfit” for such activities.

The Canadian Charter of Rights and Freedoms which was enacted in 1982 has a number of human rights provisions, one of which states that “no person shall be discriminated against on the basis of disability”. Given this constitutional background there have been an increasing number of challenges in the Courts and Human Rights Tribunals on refusals to issue licences on medical grounds including diabetes mellitus (DM).

The Civil Aviation Medical Branch (CAM) of Transport Canada is the medical body which advises the Minister of Transport on medical fitness to fly or control air traffic. CAM decided that the time had arrived to review its position on all types of diabetes, given the apparent improvement in the treatment and control of the disorder.

In order to address this issue, a conference was convened in Ottawa on April 8, 1992. Present at this conference were six eminent specialists in DM, members of CAM headquarters and regional medical staff, members of the Aviation Medicine Review Board (AB), medical representatives from the airline industry, the U.S. Federal Aviation Administration and the Canadian Diabetes Association. This document reflects the proceedings of that one day conference. 

The recommendations in this document may cause concern to some physicians, but it is felt that with the implementation of these recommendations meaningful data in this area can be developed without jeopardizing flight safety.

 


Last updated: 2004-11-26 Top of Page Important Notices